Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07546149
PHASE1

A Multiple Ascending Dose Study of LW402 in Healthy Volunteers

Sponsor: Shanghai Longwood Biopharmaceuticals Co., Ltd.

View on ClinicalTrials.gov

Summary

This Phase 1, double-blind (sponsor open), placebo controlled study will assess the safety, tolerability and pharmacokinetics of multiple doses of LW402 tablets in healthy volunteers.

Official title: A Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LW402 Tablets Following Multiple Doses in Healthy Volunteers

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

36

Start Date

2025-10-15

Completion Date

2025-12-31

Last Updated

2026-04-22

Healthy Volunteers

Yes

Interventions

DRUG

Experimental

LW402 Tablets

DRUG

Placebo

LW402 Placebo Tablets

Locations (1)

The First Affiliated Hospital of Shandong First Medical University

Jinan, Shangdong, China